Publications

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.

CLARK, RA; Mukandavire, C; Portnoy, A; WEERASURIYA, CK; Deol, A; SCARPONI, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, RC; Menzies, NA; WHITE, RG;

2023

The Lancet. Global health, (2023).11 4 10.1016/S2214-109X(23)00045-1.

Is neglect of self-clearance biassing TB vaccine impact estimates?.

SCARPONI, D; Clark, R; Weerasuriya, C; EMERY, J; HOUBEN, RM G J; WHITE, R; MCCREESH, N;

2023

medRxiv (2023). 10.1101/2023.04.11.23288400.

Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment.

Rangaka, MX; Frick, M; Churchyard, G; García-Basteiro, AL; Hatherill, M; Hanekom, W; Hill, PC; Hamada, Y; Quaife, M; Vekemans, J; WHITE, RG; Cobelens, F;

2023

The Lancet. Respiratory medicine, (2023).11 4 10.1016/s2213-2600(23)00084-x.

Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - hmer.

SCARPONI, D; Iskauskas, A; CLARK, RA; Vernon, I; McKinley, TJ; Goldstein, M; Mukandavire, C; Deol, A; Weerasuriya, C; Bakker, R; WHITE, RG; MCCREESH, N;

2023

Epidemics, (2023).43, 10.1016/j.epidem.2023.100678.

Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.

OpenSAFELY Collaborative,; PARKER, EP; Tazare, J; Hulme, WJ; Bates, C; Carr, EJ; Cockburn, J; Curtis, HJ; Fisher, L; Green, AC; Harper, S; Hester, F; Horne, EM; Loud, F; Lyon, S; MAHALINGASIVAM, V; Mehrkar, A; Nab, L; Parry, J; Santhakumaran, S; Steenkamp, R; Sterne, JA; Walker, AJ; WILLIAMSON, EJ; Willicombe, M; ... TOMLINSON, LA.

2023

BMJ Open, (2023).13 1 10.1136/bmjopen-2022-066164.

New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01 E and BCG-revaccination.

Clark, RA; Weerasuriya, CK; Portnoy, A; Mukandavire, C; Quaife, M; Bakker, R; SCARPONI, D; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2023

medRxiv (2023). 10.1101/2023.02.24.23286406.

Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking.

GRAHAM, S; Tessier, E; Stowe, J; Bernal, JL; PARKER, EP K; NITSCH, D; MILLER, E; Andrews, N; Walker, JL; McDonald, HI;

2023

Nature communications, (2023).14 1 10.1038/s41467-023-39674-0.

Cost-effectiveness of tuberculosis infection prevention and control interventions in South African clinics: a model-based economic evaluation informed by complexity science methods.

BOZZANI, FM; MCCREESH, N; Diaconu, K; GOVENDER, I; WHITE, RG; Kielmann, K; GRANT, AD; VASSALL, A;

2023

BMJ Global Health, (2023).8 2 10.1136/bmjgh-2022-010306.

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.

Portnoy, A; CLARK, RA; Quaife, M; WEERASURIYA, CK; Mukandavire, C; Bakker, R; Deol, AK; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, RG; Menzies, NA;

2023

PLOS Medicine, (2023).20 1 10.1371/journal.pmed.1004155.

First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY.

Hopcroft, L; Curtis, H; Brown, A; Hulme, W; Andrews, C; Morton, C; Inglesby, P; Morley, J; Mehrkar, A; Bacon, S; EGGO, R; MAHALINGASIVAM, V; PARKER, E; TOMLINSON, L; Bates, C; Cockburn, J; Parry, J; Hester, F; Harper, S; GOLDACRE, B; Walker, A; MacKenna, B;

2023

Wellcome Open Res (2023). 10.12688/wellcomeopenres.18735.2.